Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Meryem El Ouardi"'
Autor:
Lorena Tamarit, Meryem El Ouardi, Emilio Lence, Inmaculada Andreu, Concepcion González-Bello, Miguel A. Miranda, Ignacio Vayá
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The photobiological damage that certain drugs or their metabolites can photosensitize in proteins is generally associated with the nature of the excited species that are generated upon interaction with UVA light. In this regard, the photoinduced dama
Externí odkaz:
https://doaj.org/article/84a0dc2636fb4df292a7f01ef5a62ebe
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Gefitinib (GFT) is a selective epidermal growth factor receptor (EGFR) inhibitor clinically used for the treatment of patients with non-small cell lung cancer. Bioactivation by mainly Phase I hepatic metabolism leads to chemically reactive metabolite
Externí odkaz:
https://doaj.org/article/580e40fbc2804228b98e253c437b9f23
Autor:
Lorena Tamarit, Meryem El Ouardi, Emilio Lence, Inmaculada Andreu, Concepción González-Bello, Ignacio Vayá, Miguel A. Miranda
Publikováno v:
CHEMICAL SCIENCE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Photosensitization by drugs is directly related with the excited species and the photoinduced processes arising from interaction with UVA light. In this context, the ability of gefitinib (GFT), a tyrosine kinase inhibitor (TKI) used for the treatment
Autor:
Guillermo Garcia-Lainez, Meryem El Ouardi, Alejandro Moreno, Emilio Lence, Concepción González-Bello, Miguel A. Miranda, Inmaculada Andreu
Hepatitis C, a liver inflammation caused by the hepatitis C virus (HCV), is treated with antiviral drugs. In this context, simeprevir (SIM) is an NS3/4A protease inhibitor used in HCV genotypes 1 and 4. It is orally administered and achieves high vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c2d45aed80e904bf6a3e6d51d6b9b1
https://doi.org/10.2139/ssrn.4185908
https://doi.org/10.2139/ssrn.4185908
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Chemical Science
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
Chemical Science
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
[EN] Gefitinib (GFT) is a tyrosine kinase inhibitor currently used for the treatment of metastatic non-small cell lung cancer. Although it has been suggested that GFT can be phototoxic, there are no systematic studies on this issue. Here, the photose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29423017a8bae1770cb66babdb56ec19
https://doi.org/10.1039/d1sc03154f
https://doi.org/10.1039/d1sc03154f